Trials & Approvals
ASCO 2020: AstraZeneca and Daiichi Sankyo’s Enhertu Impresses with Benefits in Lung, Stomach and Colorectal Cancer Trials
2020-06-05
ASCO 2020: Genentech’s Novel anti-TIGIT Therapy Shows Promise in Phase II Lung Cancer Trials
2020-05-31
ASCO 2020: Results from the INFORM Registry, A Step Towards Personalized Therapy in Pediatric Cancer
2020-05-29
Novartis’ Kisqali Shows Promising Results in Advanced Breast Cancer Patients with Liver Metastases
2020-05-28
Roche’s Tecentriq Bags Landmark FDA Approval as First-Line Monotherapy for Metastatic NSCLC
2020-05-20